Data and analytics play an important role in HealthTech, so it is no wonder many of our data due diligence projects are in this hot space.
Often, investors are asking us to evaluate the impact AI could have on the target. Will it strengthen or weaken their position?
Just recently, we were looking at a company in the world of radiology, where AI is a big thing.
At the risk of oversimplification, here are some insights we gained:
1. A thorough understanding of the healthcare system, regulatory environment, and technology infrastructure is crucial.
2. There is a big difference between diagnostic and decision-supporting AI tools when it comes to building a positive business case.
3. Fragmented market of the AI providers significantly increases the complexity (and costs) of integrating their solutions.
If you are looking to invest in a HealthTech company, let us know, we’ll be glad to help assess their data and analytics value-creating potential.
Diligence
Data DD insights: Radiology
Data and analytics play an important role in HealthTech, so it is no wonder many of our data due diligence projects are in this hot space.
More Similar Posts
About us
A founder's journey
“I love talking with founders! They always have an exciting view of the world, and their motivators fascinate me.” These were the opening comments from a fellow M&A service provider yesterday. And beyond them leading to an engaging conversation about data, private equity, and consulting, they also got me thinking.
Chelsea Wilkinson
17 Aug 2022
Insights
From Data to Insights Monetisation
Intuitively, we all know that data is valuable. After all, our inboxes and news feeds are cluttered with headlines such as: ‘data is the new oil’. Plus, businesses demonstrating data-savvy behaviour have a ~200% greater market-to-book value than the market average, according to the International Data Corporation.
Chelsea Wilkinson
31 Aug 2022